McAdoo Stephen P, Tanna Anisha, Randone Olga, Tam Frederick W K, Tarzi Ruth M, Levy Jeremy B, Griffith Megan, Lightstone Liz, Cook H Terence, Cairns Tom, Pusey Charles D
Renal and Vascular Inflammation Section, Imperial College London, Multidisciplinary Vasculitis and Lupus Clinics, Imperial College Healthcare NHS Trust, London UK, Department of Nephrology, Ospedale Cardinal Massaia, Asti, Italy, Centre for Complement and Inflammation Research, Imperial College London, and Department of Pathology, Imperial College Healthcare NHS Trust, London UK Renal and Vascular Inflammation Section, Imperial College London, Multidisciplinary Vasculitis and Lupus Clinics, Imperial College Healthcare NHS Trust, London UK, Department of Nephrology, Ospedale Cardinal Massaia, Asti, Italy, Centre for Complement and Inflammation Research, Imperial College London, and Department of Pathology, Imperial College Healthcare NHS Trust, London UK
Renal and Vascular Inflammation Section, Imperial College London, Multidisciplinary Vasculitis and Lupus Clinics, Imperial College Healthcare NHS Trust, London UK, Department of Nephrology, Ospedale Cardinal Massaia, Asti, Italy, Centre for Complement and Inflammation Research, Imperial College London, and Department of Pathology, Imperial College Healthcare NHS Trust, London UK Renal and Vascular Inflammation Section, Imperial College London, Multidisciplinary Vasculitis and Lupus Clinics, Imperial College Healthcare NHS Trust, London UK, Department of Nephrology, Ospedale Cardinal Massaia, Asti, Italy, Centre for Complement and Inflammation Research, Imperial College London, and Department of Pathology, Imperial College Healthcare NHS Trust, London UK.
Rheumatology (Oxford). 2015 Jun;54(6):1025-32. doi: 10.1093/rheumatology/keu445. Epub 2014 Nov 26.
Necrotizing and crescentic GN usually presents with rapidly declining renal function, often in association with multisystem autoimmune disease, with a poor outcome if left untreated. We aimed to describe the features of patients who have presented with these histopathological findings but minimal disturbance of renal function.
We conducted a retrospective review (1995-2011) of all adult patients with native renal biopsy-proven necrotizing or crescentic GN and normal serum creatinine (<120 μmol/l) at our centre.
Thirty-eight patients were identified. The median creatinine at presentation was 84 μmol/l and the median proportion of glomeruli affected by necrosis or crescents was 32%. Clinicopathological diagnoses were ANCA-associated GN (74%), LN (18%), anti-GBM disease (5%) and HScP (3%). Only 18% of cases had pre-existing diagnoses of underlying multisystem autoimmune disease, although the majority (89%) had extra-renal manifestations accompanying the renal diagnosis. All patients received immunosuppression and most had good long-term renal outcomes (median duration of follow-up 50 months), although two progressed to end-stage renal disease within 3 years. We estimate that renal biopsy had an important influence on treatment decisions in 82% of cases.
Necrotizing and crescentic GN may present in patients with no or only minor disturbance of renal function. This often occurs in patients with underlying systemic autoimmune disease; early referral for biopsy may affect management and improve long-term outcomes in these cases.
坏死性新月体性肾小球肾炎通常表现为肾功能迅速下降,常与多系统自身免疫性疾病相关,若不治疗则预后不良。我们旨在描述具有这些组织病理学表现但肾功能仅有轻微损害的患者的特征。
我们对本中心1995年至2011年期间所有经肾活检证实为坏死性或新月体性肾小球肾炎且血清肌酐正常(<120μmol/L)的成年患者进行了回顾性研究。
共确定了38例患者。就诊时肌酐的中位数为84μmol/L,受坏死或新月体影响的肾小球比例中位数为32%。临床病理诊断为抗中性粒细胞胞浆抗体相关性肾小球肾炎(74%)、狼疮性肾炎(18%)、抗肾小球基底膜病(5%)和过敏性紫癜性肾炎(3%)。只有18%的病例先前被诊断患有潜在的多系统自身免疫性疾病,尽管大多数(89%)在肾脏诊断时伴有肾外表现。所有患者均接受了免疫抑制治疗,大多数患者长期肾脏预后良好(随访中位数时间为50个月),尽管有2例在3年内进展为终末期肾病。我们估计肾活检对82%的病例的治疗决策有重要影响。
坏死性新月体性肾小球肾炎可能在肾功能无损害或仅有轻微损害的患者中出现。这常发生在患有潜在系统性自身免疫性疾病的患者中;早期转诊进行活检可能会影响治疗并改善这些病例的长期预后。